MeSH D009472 - neuronal ceroid-lipofuscinoses
Favorite
Competitive Landscape
Events Timeline
Commercial
Clinical Trials
Competitive landscape
Events Timeline
Commercial
Company Name | Drug Name | Trade Name | Patent Expires | Approval Date | Revenue | Period |
|---|---|---|---|---|---|---|
| BioMarin Pharmaceutical | CERLIPONASE ALFA | Brineura | 2017-04-27 | $165.006 M | Q4/23-Q3/24 |
Clinical Trials
Historical Success Rate
Phase 1
100%2/2
Phase 2
33%2/6
Phase 3
50%2/4
Approved: 2Overall Success rate: 17%
All Clinical Trials
Therapeutic Areas:
All
Classification:
All
Approval:
All
Status:
All
Phases:
All
Company name | Phase 1 | Phase 2 | Phase 3 | Phase 4 | Drug Name |
|---|---|---|---|---|---|
© 2020-2024 Collaborative Drug Discovery Inc. (CDD) | Terms of Use